Kathleen S. Wright Associates Inc. Corcept Therapeutics Inc Transaction History
Kathleen S. Wright Associates Inc.
- $242 Million
- Q4 2024
A detailed history of Kathleen S. Wright Associates Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Kathleen S. Wright Associates Inc. holds 786 shares of CORT stock, worth $49,942. This represents 0.02% of its overall portfolio holdings.
Number of Shares
786
Previous 786
-0.0%
Holding current value
$49,942
Previous $36,000
8.33%
% of portfolio
0.02%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
403Shares Held
84.3MCall Options Held
1.04MPut Options Held
1.33M-
Black Rock Inc. New York, NY16.5MShares$1.05 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$643 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.1MShares$515 Million16.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.2MShares$394 Million0.49% of portfolio
-
Parallel Advisors, LLC3.83MShares$243 Million4.44% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $6.81B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...